FindTrial
Sign In

Echocardiography and short-term outcome of a pharmacoinvasive strategy and primary percutaneous coronary intervention in ST-segment elevation myocardial infarction within a regional system

Echocardiography and short-term outcome of a pharmacoinvasive strategy and primary percutaneous coronary intervention in ST-segment elevation myocardial infarction within a regional system

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800019562
Enrollment
Unknown
Registered
2018-11-18
Start date
2018-11-20
Completion date
Unknown
Last updated
2018-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute myocardial infarction

Interventions

left ventricular remolding:PCI
control:PCI
left ventricular remolding:Pharmacoinvasive
control:Pharmacoinvasive

Sponsors

The First Hospital Of Lanzhou University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Consecutive patients 18 to 75 years; 2. Persistent chest pain = 30 minutes; 3. presenting with STEMIb12 h after the onset of ischemic symptoms and with ST-segment elevation = 0.1 mV in at least two contiguous leads or new left bundle branch block; 4. Patients volunteered to join the study and signed an informed consent form (ICF).

Exclusion criteria

Exclusion criteria: 1. Expected life of non-cardiac disease <1 year; 2. Atrial fibrillation, pacing rhythm or severe aortic stenosis recorded during echocardiography; 3. History of previous myocardial infarction Or a history of PCI; 4. The patient's acoustic window is poor, and the acquired images cannot be further analyzed.

Design outcomes

Primary

MeasureTime frame
Echocardiography;—

Countries

China

Contacts

Public Contactzheng zhang

The First Hospital Of Lanzhou University

aiaichu@126.com+86 13919405976

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026